Home/Filings/4/0001140361-21-034424
4//SEC Filing

Feingold Jay 4

Accession 0001140361-21-034424

CIK 0001782223other

Filed

Oct 11, 8:00 PM ET

Accepted

Oct 12, 7:47 PM ET

Size

6.8 KB

Accession

0001140361-21-034424

Insider Transaction Report

Form 4
Period: 2021-10-07
Feingold Jay
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to buy)

    2021-10-07+436,929436,929 total
    Exercise: $16.00Exp: 2031-10-07Common Stock (436,929 underlying)
  • Award

    Common Stock

    2021-10-07+43,75043,750 total
Footnotes (2)
  • [F1]Represents shares of restricted stock that vest 25% of the first anniversary of September 13, 2021, and then in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.
  • [F2]These stock options vest 25% on the first anniversary of September 13, 2021, and then in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.

Issuer

Pyxis Oncology, Inc.

CIK 0001782223

Entity typeother

Related Parties

1
  • filerCIK 0001885838

Filing Metadata

Form type
4
Filed
Oct 11, 8:00 PM ET
Accepted
Oct 12, 7:47 PM ET
Size
6.8 KB